The benefits and risks of testosterone therapy are controversial, and ambiguities surround testosterone therapy in practice. This is reflected in the European Association of Urology and American Urological Association guidelines, as these differ on several points of management.

Late-onset Hypogonadism and Testosterone Therapy – A Summary of Guidelines from the American Urological Association and the European Association of Urology

Salonia A.;
2019-01-01

Abstract

The benefits and risks of testosterone therapy are controversial, and ambiguities surround testosterone therapy in practice. This is reflected in the European Association of Urology and American Urological Association guidelines, as these differ on several points of management.
2019
Androgens
Erectile dysfunction
Hypogonadism
Libido
Lifestyle
Major cardiac adverse event
Prostate cancer
Sexual desire
Testosterone
Testosterone deficiency
Testosterone replacement therapy
Adult
Age of Onset
Humans
Hypogonadism
Male
Testosterone
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/107006
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact